Elisabet Londos
81 – 90 of 152
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Evaluation of the Cerebrospinal Fluid Amyloid-beta(1-42)/Amyloid-beta(1-40) Ratio Measured by Alpha-LISA to Distinguish Alzheimer's Disease from Other Dementia Disorders
(
- Contribution to journal › Article
-
Mark
Multidisciplinary intervention reducing readmissions in medical inpatients: a prospective, non-randomized study
(
- Contribution to journal › Article
- 2012
-
Mark
The impact of autonomic dysfunction on survival in patients with dementia with lewy bodies and Parkinson's disease with dementia.
(
- Contribution to journal › Article
-
Mark
Comparison of Brief Cognitive Tests and CSF Biomarkers in Predicting Alzheimer's Disease in Mild Cognitive Impairment: Six-Year Follow-Up Study.
(
- Contribution to journal › Article
-
Mark
Cognitive impairment is undetected in medical inpatients: a study of mortality and recognition amongst healthcare professionals
(
- Contribution to journal › Article
-
Mark
Gender-dependent levels of hyaluronic acid in cerebrospinal fluid of patients with neurodegenerative dementia.
(
- Contribution to journal › Article
-
Mark
A Pilot Study Examining Associations between DYRK1A and alpha-Synuclein Dementias
(
- Contribution to journal › Article
-
Mark
Altered CSF Orexin and α-Synuclein Levels in Dementia Patients.
(
- Contribution to journal › Article
-
Mark
No association of COMT val158met polymorphism and psychotic symptoms in Lewy body dementias
(
- Contribution to journal › Article
-
Mark
Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
(
- Contribution to journal › Article